Issue link: http://osercommunicationsgroup.uberflip.com/i/562595
O s e r C o m m u n i c a t i o n s G r o u p D e n v e r Tu e s d a y, A u g u s t 2 5 , 2 0 1 5 AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS An interview with Kevin Farkas, Executive Vice President, Sales and Business Development, Active International. CDD: What is corporate trade? KF: Corporate trade is a flexible financial tool that enables manufacturers and retail- ers to utilize their underperforming assets, coupled with cash, to purchase pre-budget- ed expenses like media, retail marketing, events and hospitality, freight and UNDERSTANDING CORPORATE TRADE Established in 2010, TAGI Pharma is a wholly owned sub- sidiary of Precision Dose, Inc., founded with the purpose of penetrating the retail segment and expanding generic opportunities. The Emergence of TAGI With a robust pipeline and product mix, TAGI Pharma is providing market opportunities in both retail and institu- tional segments. It maintains product emphasis on tablets and capsules while encompassing liquids, powders, Most think of sum- mer as a time for vacations, spending time outside and weekend barbeques. It can also mark what many see as "itch season." Bug bites, poison ivy and allergies can all send consumers running to the anti-itch aisle to find a solution that will stop that itch. For retailers, this can mean a big spike in sales for the anti-itch category. Last summer saw sales of $180,397,932 (June-Aug, US-MULO Anti-Itch) The Mentholatum Company credits a focus on innovation and con- sumer communication as a key factor driving the record-setting growth that it has experienced over the last 52 weeks. This upward trend was led by its Softlips, Rohto and Mentholatum brands. According to Joe DeMarco, National Sales Manager, "It's not enough to just get these products into retail distribution. We're also investing in marketing and advertising programs to raise brand awareness and drive demand at the An interview with Chirag Patel, Co-Chief Executive Officer and Chairman, Amneal Pharmaceuticals CDD: What increased role do you see Amneal playing in retail pharma- cy? CP: Amneal is fully committed to retail pharmacy. We want retail to get stronger and play a more integral part in healthcare delivery as a whole, and we plan to enable this segment to thrive by supplying Continued on Page 84 An interview with Mark Trudeau, President and Chief Executive Officer, Mallinckrodt. CDD: It has been more than two years since Mallinckrodt became an independent, public company – what has the company accomplished since its spin off? MT: Mallinckrodt has been in business for nearly 150 years. A significant con- tributing factor to our success is our Continued on Page 85 Continued on Page 85 TAGI PHARMA: EXPANDING GENERIC OPPORTUNITIES IS THERE REALLY AN "ITCH SEASON"? AMNEAL: DEDICATED TO QUALITY MENTHOLATUM GROWING MORE THAN TWICE AS FAST AS ITS CATEGORIES MALLINCKRODT: MANAGING COMPLEXITY, IMPROVING LIVES Continued on Page 77 Continued on Page 84 Continued on Page 84 A c c r e d i t a t i o n Commission for Health Care (ACHC) is an accreditation organization with 29 years of experience providing a comprehensive line of nationally recognized accredita- tion programs. According to its mission, ACHC is dedicated to partnering with healthcare providers to deliver a collabo- rative experience that is second to none. The ACHC philosophy is at the founda- tion of programs that are flexible without compromising integrity, which results in an educational approach that has gained Improving medica- tion adherence saves money and lives. When patients don't take their medications cor- rectly or for the prescribed duration, it costs the U.S. healthcare system more than $230 billion annually, contributes to 10 percent of all hospitalizations and results in 125,000 deaths. Up to 30 per- cent of prescribed medications are never filled, and of those filled, up to 50 per- cent are taken incorrectly. A root cause is insufficient or inef- fective interaction between patient and Continued on Page 85 ACHC OFFERS PREMIER ACCREDITATION SOLUTION PATIENT COMMUNICATION IMPROVES MEDICATION, PHARMACY PERFORMANCE Continued on Page 84